ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the posoleucel Phase 3 Studies were ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of AlloVir, Inc. (NASDAQ: ALVR) and Kalaris Therapeutics is fair to AlloVir shareholders.

AlloVir (NASDAQ:ALVR) just reported results for the first quarter of 2024. AlloVir reported earnings per share of -26 cents. This was below the analyst estimate for EPS of -18 cents. The company did ...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of AlloVir, Inc. ...

AlloVir (NASDAQ:ALVR) just reported results for the fourth quarter of 2023. AlloVir reported earnings per share of -53 cents. This was below the analyst estimate for EPS of -43 cents. The company did ...